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Abstract
A homozygous disruption or genetic mutation of the bag3 gene causes progressive myofibrillar myopathy in mouse and
human skeletal and cardiac muscle disorder while mutations in the small heat shock protein aB-crystallin gene (CRYAB) are
reported to be responsible for myofibrillar myopathy. Here, we demonstrate that BAG3 directly binds to wild-type aB-
crystallin and the aB-crystallin mutant R120G, via the intermediate domain of BAG3. Peptides that inhibit this interaction in
an in vitro binding assay indicate that two conserved Ile-Pro-Val regions of BAG3 are involved in the interaction with aB-
crystallin, which is similar to results showing BAG3 binding to HspB8 and HspB6. BAG3 overexpression increased aB-
crystallin R120G solubility and inhibited its intracellular aggregation in HEK293 cells. BAG3 suppressed cell death induced by
aB-crystallin R120G overexpression in differentiating C2C12 mouse myoblast cells. Our findings indicate a novel function for
BAG3 in inhibiting protein aggregation caused by the genetic mutation of CRYAB responsible for human myofibrillar
myopathy.
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Introduction
Myofibrillar myopathy is a genetically heterogeneous group of
diseases characterized by disrupted Z-disc structure and myofi-
brillar degeneration [1]. Mutations in genes encoding Z-disc
components or their interacting proteins have been identified as
being responsible for myofibrillar myopathy development [2,3].
Myofibrillar myopathy is sometimes accompanied by cytosolic
aggregated proteins and ectopic accumulation of various different
myofibrillar proteins, suggesting that the disease may be due to
abnormalities in protein folding and Z-disc protein assembly [4,5].
aB-crystallin expression predominantly occurs in the eye lens,
heart, and skeletal muscle, and point mutations in CRYAB cause
human cataracts and myofibrillar myopathy. At least four different
mutations in CRYAB have been detected in myofibrillar myopathy
patients: R120G (substitution of Glycine for Arginine at amino
acid 120), 464DelCT (a C-terminal truncation), Q151X (a C-
terminal truncation), and G154S (substitution of Serine for
Glycine at amino acid 154) [5,6]. Among these, the R120G
mutation has been characterized extensively [7,8,9,10]. This
mutation produces structural changes that result in aggregation of
the protein in cells [4,11]. The aB-crystallin R120G mutant also
causes aberrant structural changes in the intermediate cytoskeletal
protein desmin. Heart-specific overexpression of aB-crystallin
R120G has been used to analyze the effects of this mutation on
apoptosis in vivo [12]. Upon aB-crystallin R120G overexpression,
amyloidogenic oligomers were detected in the heart, suggesting
that toxic oligomers generated by this mutation may affect
apoptotic pathways by inducing mitochondrial dysfunction and
disrupting the cytoskeletal network [8,12].
Protein structure is essential for proper protein function.
Although the information for protein structure is conserved at
the primary amino acid sequence level, many proteins are easily
misfolded in the crowded cellular milieu. Protein folding systems
are widely conserved across species, and play a significant role in
maintaining proper protein structure in cells. The importance of
protein folding is well recognized since many diseases result from
abnormal protein folding. Molecular chaperones and co-chaper-
ones are vital for correct protein folding, inhibition of protein
aggregation, and degradation of misfolded proteins. There are two
major cytosolic molecular chaperones: stress-inducible Hsp70 and
constitutively expressed Hsc70. BAG3 is a member of the Bcl-2-
associated athanogene (BAG) family of proteins that regulate
Hsp70/Hsc70 chaperone activity via their conserved C-terminal
domain [13]. The upstream sequences of the BAG family proteins
are quite divergent, which presumably allows the different family
members to act in a variety of settings. BAG3 carries both a WW
domain and PXXP motif, which are well known protein
interaction motifs [14,15].
BAG3 null mutation mice show severe striated muscle
degeneration and early lethality, characterized by myofibrillar
myopathy [16]. Our recent research revealed the important role of
BAG3 in the maintenance of myofibriller structure [17].
Furthermore, a mutation in the bag3 gene, that results in
substitution of proline for leucine at amino acid 209 (P209L),
was identified in patients having progressive-type myofibrillar
myopathy [18,19]. In addition, BAG3 protein co-localized with
sites of desmin aggregation found in skeletal muscle from canine
myofibrillar myopathy [20]. These data suggest that BAG3 has
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important roles in preventing protein aggregation and maintaining
myofibrillar structure in striated muscle.
Here we report that BAG3 directly binds to wild-type aB-
crystallin and R120G aB-crystallin and inhibits the aggregation
and increased apoptosis induced by this mutation. This study
reveals a potential connection between BAG3 and small heat
shock proteins to prevent the protein aggregation and cell death
that occurs in myofibrillar myopathy.
Materials and Methods
Antibodies
A polyclonal antibody that recognizes BAG3 was described
previously [16]. Mouse monoclonal antibodies for FLAG and a-
actinin (sarcomeric) were purchased from SIGMA (SIGMA, St
Louis, MO) while antibodies for aB-crystallin and actin were
obtained from Assay Designs, Inc. (Ann Arbor, MI) and
Neomarker (Fremont, CA), respectively. All other antibodies were
from Santa Cruz Biotechnology (Santa Cruz, CA).
Plasmid Construction
The plasmid for human BAG3 was described in [16,21]. cDNAs
for human aB-crystallin wild type and its mutant (R120G) inserted
into pRcCMV were a generous gift from Drs. H. Ito and K. Kato
(Aichi Human Service Center). Hsc70 cDNA was amplified using
RNA extracted from HEK293 cell, followed by RT-PCR and
subcloned into pcDNA3 Flag vecotor (Genbank ID: NP_006588).
For expression of GST fusion proteins in E. coli strain BL21, these
cDNAs were also subcloned into pGEX-6P-1 (Amersham
Biosciences, Uppsala, Sweden). Adeno-X Expression System Kit
was used for adenovirus production (BD Biosciences Clontech).
Adenoviral vector encoding b-galactosidase was used as a control.
Cell culture
Cardiomyocytes were isolated from hearts of neonatal rats
(Harlan, Indianapolis, IN) using the Neonatal Cardiomyocyte
Isolation System (Worthington Biochemical Corporation, Lake-
wood, NJ). C2C12 and HEK293 cells were purchased from
ATCC (Manassas, VA). These cells were cultured at 37uC in
Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
FBS supplemented with penicillin and streptomycin. Transpass
(New England Biolabs) or Lipofectamine 2000 (Invitrogene) was
used for transfection. For differentiation of C2C12 cells, growth
medium was replaced for differentiation medium (DMEM
containing 2% horse serum supplemented with penicillin and
streptomycin).
Proteins
GST-BAG3 and GST-aB-crystallin were expressed in E. coli
strain BL21. Cells were lysed in lysozyme lysis buffer (50 mM Tris,
pH 8.0, 2 mM EDTA, 100 mM NaCl, 1% Triton X-100,
200 mM NaSCN, 1 mg/ml lysozyme) supplemented with a
mixture of protease inhibitors (CompleteTM, Roche Diagnostics).
After brief sonication, the cell lysate was centrifuged at 18,0006g
for 15 min at 4uC, and the supernatant incubated with GSH-
sepharose 4B (Amersham Pharmacia Biosciences) for 2 hrs. The
beads were then washed four times with lysis buffer. Protein
expression and purification was confirmed by immunoblot assay.
Immunoprecipitation
For in vivo association, HEK293 cells were transiently transfect-
ed with various plasmids. 48 hours after transfection, cells were
lysed in immunoprecipitation buffer (20 mM Tris, pH 7.5,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10 mM NAF,
2 mM Na3VO4, 2 mM PMSF, and 1% TritonX-100) supple-
mented with a mixture of protease inhibitors (CompleteTM,
Roche Diagnostics). Pre-cleared lysates were subjected to immu-
noprecipitation with indicated antibodies. Precipitated proteins
were eluted from the beads by boiling in SDS sample buffer, and
separated by SDS-PAGE. Immunoblot assays were performed
using the indicated antibodies.
In vitro binding
To detect protein interactions in vitro, a GST pull-down assay
was performed. GST, GST fusion aB-crystallin, and BAG3 were
expressed in BL21 cells, induced by 1 mM isopropyl-1-thio-b-
galactopyranoside, and purified using glutathione-Sepharose
beads (Amersham Pharmacia Bioscience, Uppsala, Sweden).
Purified proteins were incubated in immunoprecipitation buffer
followed by precipitation with glutathione-Sepharose beads
(Amersham Pharmacia Bioscience). Bound proteins were eluted
from the beads by boiling in SDS sample buffer, separated by
SDS-PAGE, and visualized by immunoblotting using anti-BAG3
or anti-aB-crystallin antibody.
Cell Lysis
HEK293 cells were lysed in lysis buffer A (10 mM Tris, pH 8.0,
150 mM NaCl, 2% SDS, 10 mM NaF, 2 mM Na3VO4, 2 mM
PMSF, and 1:50 protease inhibitor cocktail), and sonicated; this
sample represented the ‘‘total fraction’’. Lysis buffer B (20 mM
Tris, pH 7.4, 150 mM NaCl, 0.001% Tween-20, 10 mM NaF,
2 mM Na3VO4, 2 mM PMSF, and 1:50 protease inhibitor
cocktail) was used to isolate the soluble fraction. After homoge-
nization, the sample was transferred to a tube, and centrifuged at
14,0006g for 15 minutes at 4uC. The supernatant was transferred
to a new tube to represent the ‘‘soluble fraction’’.
Immunofluorescence
For staining of cultured cells, cells were washed with PBS, and
fixed with 4% paraformaldehyde in PBS for 5 minutes. After three
5-min washes with PBS, the fixed samples were incubated in 0.2%
Triton X-100 in PBS for 3 minutes and blocked with 2% BSA in
PBS for 1 hour. Various primary antibodies used for staining were
incubated with the samples for 1 hour at room temperature. After
washing with PBS, the samples were incubated with Alexa Fluor
conjugated antibodies (Alexa Fluor 488 goat anti-mouse IgG and
Alexa Fluor 594 goat anti-rabbit IgG (Molecular Probes, Eugene,
OR)). After washing with PBS, samples were mounted using
Vectashield with Dapi (49, 6-diamidino-2-phenylindole: Vector
Laboratories, Burlingame, CA). For apoptosis assays, cells were
stained with aB-crystallin and DAPI, and cells containing nuclear
fragmentation were counted.
Immunoblotting
Extracted proteins were subjected to SDS-polyacrylamide gel
electrophoresis (SDS-PAGE), transferred onto polyvinylidene
difluoride membranes (Amersham Pharmacia Biosciences), and
probed with the indicated antibodies. Signals were visualized using
ECL Plus reagents (Amersham Pharmacia Biosciences). Protein
concentrations were measured using the BCL protein assay
reagent (PIERCE, Rockford, IL).
Statistics
Data are expressed as mean6 S.E. A paired Student’s t-test was
used to analyze differences between two groups, and p vales of
,0.05 or ,0.01 were considered significant. ‘‘n.s’’ stands for not
significant. Image J is a public domain, Java-based image
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processing program developed at the National Institutes of Health
(NIH).
Results
BAG3 interacts with aB-crystallin through the BAG3
intermediate domain
BAG3 is highly expressed in striated muscle and null mutations
in BAG3 are implicated in myofibrillar myopathy [16]. The small
heat shock protein (sHsp), aB-crystallin, is also expressed in
striated muscle at relatively high levels and a mutation in this
protein (R120G) is also reported to cause myofibrillar myopathy
[4]. Thus, we investigated whether BAG3 and aB-crystallin are
associated in cultured striated muscle, in this case, rat neonatal
cardiomyocytes. Flag-tagged BAG3 was expressed in rat neonatal
cardiomyocytes using adenovirus, and an immunoprecipitation
assay was performed. Immunocomplexes were prepared using
anti-Flag antibody, followed by SDS-PAGE to detect endogenous
aB-crystallin. The results showed that BAG3 bound to aB-
crystallin as well as Hsc70 (Figure 1A). To identify the binding
region required for this interaction, we expressed various BAG3
mutants in HEK293 cells with aB-crystallin, and performed
immunoprecipitation assays. The BAG3 protein possesses three
known protein interaction motifs: the WW domain, which
interacts with the PPXY sequence found in various subcellular
compartments [14]; the PxxP motif, a candidate interaction site
for SH3 domain proteins [22]; and the BAG domain, which
interacts with Hsp70/Hsc70. We also constructed a BAG3 mutant
(DM1) that lacks the region between the WW domain and PxxP
motif (Figure 1B). While wild-type BAG3 interacted with both aB-
crystallin and Hsc70, the DM1 mutant failed to associate only with
aB-crystallin, while the DBAG mutant did not interact with Hsc70
(Figure 1C), suggesting that BAG3 binds to both aB-crystallin and
Hsc70 via two distinct regions. Recently, Margit et al. explored the
precise region of BAG3 involved in binding with other sHsps, and
found that HspB8 and HspB6 required BAG3 amino acid residues
87–101 and 200–213, respectively [21]. Since this region is located
in the BAG3 intermediate domain, we verified whether aB-
crystallin also binds to BAG3 at the same region. We expressed in
HEK293 cells aB-crystallin along with His-BAG3 wild type or its
mutant (DM2: deletion that includes both aa 87–101 and aa 200–
213), which lacks the interacting domain for HspB8/HspB6, and
the cell extract was incubated with anti-His antibody to isolate
His-tagged proteins. As expected, the interaction of BAG3 with
aB-crystallin was abolished when the BAG3DM2 mutant was
expressed instead of wild type BAG3 (Figure 1D). The direct
interaction between BAG3 and aB-crystallin was also confirmed
by an in vitro binding assay using purified proteins (Figure 1E). We
generated two peptides corresponding to aa 87–101 and aa 200–
213 of BAG3, and performed a competition assay using purified
BAG3 and aB-crystallin. Each peptide partially hampered the
interaction between BAG3 and aB-crystallin, and the interaction
was completely abolished when both peptides were present
(Figure 1F).
BAG3 interacts with aB-crystallin R120G
The previous experiments indicate a direct interaction between
BAG3 and aB-crystallin. To confirm whether BAG3 also interacts
with aB-crystallin mutants in cells, either wild-type or aB-crystallin
R120G was expressed with Flag-tagged BAG3 in HEK293 cells,
and an immunoprecipitation assay was performed using anti-Flag
antibody. aB-crystallin R120G alone was expressed at lower levels
compared to wild-type, but the band intensity increased noticeably
when BAG3 was co-expressed (Figure 2A). Since BAG3
overexpression with wild type aB-crystallin did not show increased
signals, the interaction of BAG3 with aB-crystallin R120G may
increase the stability of R120G aB-crystallin perhaps due to
conformational changes [23]. In this assay, we used immunopre-
cipitation buffer (Materials and Methods) for cell lysis. The
difference in aB-crystallin signal in Figure 2A suggests that aB-
crystallin R120G be in the insoluble fraction in the absence of
BAG3 co-expression, but in the presence of BAG3 overexpression,
the solubility of aB-crystallin R120G is enhanced. To investigate
whether BAG3 recognizes R120G aB-crystallin directly, we
purified wild type aB-crystallin and aB-crystallin R120G from
E.coli, and mixed the proteins with GST or GST-BAG3 in a pull-
down assay using Glutathione-sepharose beads. Increased
amounts of aB-crystallin R120G precipitated with BAG3 relative
to wild type aB-crystallin (Figure 2B). The same result was
obtained using purified BAG3 mixed with GST-aB-crystallin,
followed by pulled down with glutathione sepharose beads
(Figure 2C).
BAG3 reduces aggregation and increases solubility of aB-
crystallin mutant
Since BAG3 binds to both wild-type and R120G aB-crystallin,
we investigated whether BAG3 overexpression affects the
aggregation seen for R120G aB-crystallin. When wild type aB-
crystallin was expressed in HEK293 cells, aB-crystallin had a
diffuse cytosolic localization (Figure 3A). In contrast, aB-crystallin
R120G expression in HEK293 cells produced a fine granular
pattern with significant perinuclear aggregation (Figure 3A). To
examine the effect of BAG3 overexpression on aB-crystallin
aggregation, HEK293 cells were co-transfected with Flag-tagged-
BAG3 and aB-crystallin R120G expression vectors. Immunocy-
tochemical analyses were performed using anti-Flag and -aB-
crystallin antibodies. In the presence of BAG3 expression, the
aggregation that was observed for nearly half the cells expressing
aB-crystallin R120G disappeared (Figure 3A). The yellow staining
seen in the merged image of cells overexpressing Flag BAG3 and
aB-crystallin R120G (right bottom) indicates that BAG3 and aB-
crystallin are colocalized (right bottom). We used aB-crystallin
antibody to detect overexpressed protein, due to the low levels of
endogenous aB-crystallin in HEK293 with non-tagged construct
of aB-crystallin expression vector (Figure 3C). To perform
statistical analysis of aggregation, we calculated the number of
cells where aggregation was present and absent. As shown in
Figure 3B, aB-crystallin R120G overexpression induces aggregates
in more than half the cells. Upon overexpression of BAG3, the
number of cells with aggregation was dramatically reduced,
indicating that BAG3 inhibits aggregation of mutant aB-crystallin
(Figure 3B).
To investigate whether BAG3 enhances the solubility of aB-
crystallin R120G, a western blot analysis was performed using two
different lysis buffers, which either did (containing 2% SDS) or did
not (containing 0.001% Triton X-100) solubilize protein aggre-
gates. As shown in Figure 3C, the signal of wild type aB-crystallin
(lane 2) has a similar intensity as R120G aB-crystallin (lane 6).
With overexpression of BAG3, a higher intensity signal for aB-
crystallin (lane 3, 4, 5) and R120G aB-crystallin (lane 7, 8, 9) was
detected (Figure 3C upper panel) [23]. In contrast, using buffer
with 0.001% Triton, which does not solubilize aggregates, R120G
aB-crystallin was mostly in the insoluble fraction (Figure 3D lane
6). Overepxression of BAG3 increased the intensity of R120G aB-
crystallin signal even with non-solubilizing 0.001% Triton buffer,
indicating that BAG3 increased the solubility of R120G aB-
crystallin. This could also explain the higher intensity for R120G
aB-crystallin seen when BAG3 is co-expressed in Figure 2A.
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To determine the effect of Hsc70/Hsp70 interaction in
prevention of R120G aggregation, we used a BAG3 deletion
mutant of the BAG domain (BAG3DC) and overexpression of
Hsc70 in the aggregation assay. The expression vectors, pcDNA3
BAG3DC, pcDNA3 wild type BAG3 (BAG3FL), pcDNA3 empty
plasmids (mock) and pcDNA3 Flag-Hsc70, were transfected with
aB-crystallin R120G expression vector, followed by immunohis-
tomical analysis and statistical analysis of aggregation using anti-
aB-crystallin antibody described above (Figure 3A and B).
Figure 3E shows the effect of BAG3 with or without the BAG
Figure 1. BAG3 binds aB-crystallin directly through BAG3 intermediate region. (A) BAG3 interacts with aB-crystallin in rat cardiomyocytes.
Cardiomyocytes were isolated from rat hearts, and Flag-tagged BAG3 was expressed using adenovirus. Cell extracts were immunoprecipitated with
anti-Flag antibody, and the sample was applied to SDS-PAGE. Anti-aB-crystallin antibody was used to detect aB-crystallin. The same membrane was
blotted with anti-Hsc70 and anti-aActinin antibody for a positive and negative control, respectively. No actinin interacting was observed (negative
control). (B) Schematic representation of the primary structure of wild-type BAG3 and its mutants. The BAG3DC construct lacks the BAG domain. The
BAG3 intermediate domain and amino acids from 87–101 and from 200 to 213 are deleted in BAG3DM1 and BAG3DM2, respectively. Amino acid
sequences between residues 87–101 and 200–213 are shown. (C) Co-precipitation of aB-crystallin and BAG3. Flag-tagged BAG3 or mutants were
expressed with aB-crystallin in HEK293 cells, and cell extracts were immunoprecipitated with anti-Flag antibody. aB-crystallin was detected with anti-
aB-crystallin antibody. Anti-Hsc70 antibody was used to detect Hsc70 precipitation with BAG3. The cell extracts were also applied to an
immunoblotting assay to verify expression. (D) BAG3 interacts with aB-crystallin via amino acids 87–101 and 200–213. His-tagged BAG3 or BAG3M2 was
expressed with aB-crystallin in HEK293 cells, and BAG3 was precipitated with anti-His antibody. Co-precipitated aB-crystallin was detected with anti-
aB-crystallin antibody (upper panel). The same membrane was blotted with anti-His antibody (bottom panel). (E) Direct interaction of BAG3 with aB-
crystallin. Left panel: GST protein fused to BAG3 was expressed in Escherichia coli, and purified fusion proteins were incubated with purified aB-
crystallin, followed by precipitation with GSH beads. After SDS-PAGE, aB-crystallin was detected using anti-aB-crystallin antibody. Right panel: GST
fusion proteins used in the experiment were visualized with CBB staining to verify the quality and quantity. (F) Competition assay with peptides.
Purified GST or GST-BAG3 was incubated with purified aB-crystallin in the presence or absence of peptides corresponding to amino acids 87–101 or
200–213 of BAG3 at indicated concentrations. The precipitated samples with GSH beads were loaded onto SDS-PAGE, followed by an
immunoblotting assay using anti-aB-crystallin antibody.
doi:10.1371/journal.pone.0016828.g001
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domain and overexpression of Hsc70 in aggregation caused by the
R120G mutant using immunohistochemical assay. Deletion of the
BAG domain in BAG3 (BAG3DC) still induced a significant
reduction in aggregation formation. Overexpression of Hsc70 with
BAG3 (BAG3FL+Hsc70) did not cause a significant further
reduction of R120G aggregation compared with BAG3DC+
Hsc70. From these results, it appears that the effect of BAG3 in
prevention of aggregation caused by R120G mutant does not
depend on its interaction with Hsp70/Hsc70.
BAG3 reduces cell toxicity caused by aB-crystallin
mutation
R120G aB-crystallin is reportedly toxic to cells, and induces
cell death in striated muscle [8,10,24,25]. To investigate whether
the toxicity of R120G aB-crystallin is also inhibited by BAG3
overexpression, R120G aB-crystallin was expressed with or
without Flag-tagged BAG3 in the C2C12 mouse myoblast cell
line, and the number of apoptotic cells during myoblast
differentiation counted. There was no obvious difference in the
apoptotic cell number among cells expressing wild type aB-
crystallin, mutant aB-crystallin and mutant aB-crystallin togeth-
er with BAG3 in C2C12 myoblasts. Upon differentiation
initiation, more apoptosis was observed for R120G aB-crystallin
expressing cells. However, the number of apoptotic cells
decreased when BAG3 was co-expressed with R120G aB-
crystallin (Figure 4).
Discussion
During investigations on myofibrillar myopathy caused by
ablation of the bag3 gene, we identified a direct interaction
between aB-crystallin and BAG3. This interaction can inhibit the
aggregation and toxicity caused by a point mutation in aB-
crystallin, R120G aB-crystallin [4]. Hsp70 and small heat shock
protein family molecular chaperones have been reported to be
critical players in human degenerative diseases [26]. Interestingly,
genetic mutations of small heat shock proteins are found in
diseases involving neurons, muscular tissues and ocular lens that
arise from defects in protein folding. Four mutations (R120G,
464delCT, Q151X and G154S) in the aB-crystallin gene were
identified in inherited myofibrillar myopathy [4,5,6]. Genetic
mutations in the intermediate filament protein desmin also cause
mis-assembly and aggregation of desmin, resulting in myofibrillar
myopathy having similar pathological features [7]. Thus, the
desmin aggregation occurring in myofibrillar myopathy attribut-
able to mutations in aB-crystallin is due to the loss of its chaperone
function [11,27,28]. Homozygous null mutation of desmin or
CRYAB only induces very mild myopathy compared to myopathy
induced by mutated aB-crystallin (R120G), indicating that the
Figure 2. BAG3 recognizes folding status of aB-crystallin. (A) BAG3 binds to mutant type of aB-crystallin strongly. Wild type (WT) or mutant
(R120G) aB-crystallin was expressed in HEK293 cells with Flag-tagged BAG3, and the cell lysate was mixed with anti-Flag antibody. Precipitated
samples were analyzed by SDS-PAGE using anti-aB-crystallin (upper panel), Flag-tagged BAG3 (middle panel), and actin (lower panel). The sample
before immunoprecipitation was also loaded to confirm protein expression (right four lanes). (B) Direct recognition of mutant aB-crystallin by BAG3.
Purified GST or GST-fused BAG3 beads were incubated with purified aB-crystallin wild type (WT) or mutant (R120G), and a pull-down assay was
performed. Precipitated aB-crystallin was detected with anti-aB-crystallin antibody (upper panel). The same membrane stained with Ponceau is
shown below. Mutated aB-crystallin preferentially binds to BAG3. Purified GST, GST-fused aB-crystallin wild type (WT) or mutant (R120G) was mixed
with purified BAG3 for a pull-down assay. The detection of BAG3 was achieved with anti-BAG3 antibody after SDS-PAGE. The same membrane was
stained with Ponceau (lower panel).
doi:10.1371/journal.pone.0016828.g002
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Figure 3. Overexpression of BAG3 suppresses aggregation of mutant aB-crystallin and increases its solubility. (A) Aggregation of
mutant aB-crystallin is cleared by BAG3. HEK293 cells were transfected with plasmids for wild type or mutant aB-crystallin with or without Flag-tagged
BAG3. Two days later, cells were fixed and aB-crystallin and Flag-tagged BAG3 were stained with anti-aB-crystallin antibody (red in color images) and
Flag-antibody (green in color images), respectively. Merged images are also shown (Merge). (B) BAG3 cleared aggregation caused by aB-crystallin
mutant. After staining of aB-crystallin, the number of cells containing aB-crystallin aggregation were counted and statistically analyzed. The Y-axis
indicates the percentage of cells displaying aB-crystallin aggregation. (C) BAG3 increases stability of mutant type of aB-crystallin in HEK293 cells. HEK293
cells were cultured in a 24-well dish and plasmids for aB-crystallin wild type (WT) or mutant (R120G) were transfected (0.2 mg each) with or without
the plasmid for Flag-tagged BAG3. The amount of BAG3 plasmid was increased gradually (0.05, 0.15, and 0.3 mg). After two days, cells were lysed in
lysis buffer A (10 mM Tris, pH 8.0, 150 mM NaCl, 2% SDS, 10 mM NaF, 2 mM Na3VO4, 2 mM PMSF, and 1:50 protease inhibitor cocktail), and
sonicated. The sample was loaded onto SDS-PAGE, and an immunoblotting assay performed with anti-aB-crystallin (first panel), Flag (second panel),
and actin antibody (third panel). GFP plasmid was transfected together to monitor transfection efficiency, and detected with anti-GFP antibody
(bottom panel). (D) BAG3 increases solubility of mutant type of aB-crystallin in HEK293 cells. The same set of transfections described above in ‘‘C’’ were
done, but lysis buffer B was used instead of lysis buffer A (lysis buffer B; 20 mM Tris, pH 7.4, 150 mM NaCl, 0.001% Tween-20, 10 mM NaF, 2 mM
Na3VO4, 2 mM PMSF, and 1:50 protease inhibitor cocktail). After homogenization, the sample was transferred to a tube, and centrifuged at 14,0006g
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toxicity may be induced by aggregation itself [7]. This line of
thinking is supported by the ability of R120G aB-crystallin to
generate pathogenic aggregation and toxic amyloidgenic oligo-
mers both in vivo and in vitro [12]. Since aB-crystallin has
chaperone activity and interacts with other chaperones, this
aggregation of mutant aB-crystallin may be inhibited by different
molecular chaperones. aB-crystallin R120G aggregation is
reversed by overexpression of Hsp27, suggesting that Hsp27 can
be a molecular chaperone for R120G aB-crystallin [29]. aB-
crystallin R120G aggregation is also inhibited by wild type aB-
crystallin, Hsp27 and HspB8 [30]. In addition, Hsp70 and its co-
chaperone CHIP inhibit aggregation of aB-crystallin R120G [30].
Since BAG3 is a co-chaperone of Hsp70/Hsc70 and an
interacting partner of HspB8, inhibition of aB-crystallin R120G
aggregation can also be modified by interaction with HspB8 or
Hsp70. Multiple protein complexes with BAG3, wild type aB-
crystallin, HspB8 and Hsp70 may cooperatively inhibit protein
aggregation generated by mutations in aB-crystallin. As shown in
Figure 3E, BAG3 with deletion of the BAG domain still inhibits
aggregation and apoptosis induced by the aB-crystallin R120G
mutant, suggesting that BAG3 may not use Hsp70/Hsc70 for
inhibiting aggregation in our system. In addition, overexpression
of Hsc70 produced no additional effect in the presence of the
BAG3 and BAG3 mutant. This data indicated that Hsc70 might
not work synergistically with BAG3 in preventing aggregation.
However, since Hsp70 and small Hsp chaperone systems have
similar effects on R120G aggregation and BAG3 binds to both
chaperones, it is possible that small heat shock protein interaction
with BAG3 is enough to prevent aggregation in our assay system.
Hsp70 inhibits R120G aggregation with ubiquitin ligase CHIP or
co-chaperone Hdj1, suggesting that a particular complex with co-
chaperones might be critical for Hsp70 to inhibit R120G
aggregation. Thus, further investigation is necessary to elucidate
the functional connection of BAG3 with Hsp70 complexes in
prevention of R120G aggregation.
A BAG3 null mutation in mice results in severe progressive
myofibrillar myopathy [16]. Recently, a genetic mutation where
Proline is mutated to Leucine at amino acid position 209 of BAG3
has been reported in patients having severe myofibrillar myopathy
[18,19]. Interestingly, amino acid 209 is located in the region of
BAG3 that interacts with small heat shock proteins (HspB6, B8
[21] and aB-crystallin Figure 1F). Recently, the relationship
between molecular chaperones and autophagy has been exten-
sively studied. HspB8, a small heat-shock protein, forms a stable
complex with BAG3, and this complex accelerates the degradation
of mutant Huntingtin protein through autophagy [21,23]. We
evaluated autophagy in our system, but found no evidence of
accelerating autophagy in preventing aggregation of R120G aB-
crystallin (not shown).
In Figure 2, pull down experiments indicated that BAG3
appears to have a greater affinity for R120G aB-crystallin relative
to wild type. Since aB-crystallin forms multimers/dimers, it is
possible that the molar ratio may be altered in the R120G aB-
crystallin and BAG3 interaction. However, using a GST fusion of
aB-crystallin for pull down experiments with BAG3 (Figure 2B
right), only GST R120GaB-crystallin showed higher signals upon
BAG3 precipitation, suggesting that R120G aB-crystallin may
have a greater affinity for BAG3 compared to wild-type. This
result is in agreement with finding that HspB8 interacts with aB-
crystallin R120G to a greater extent than wild-type aB-crystallin,
suggesting that this chaperone is recognizing a misfolded version of
aB-crystallin [30]. Further experiments will be necessary to
elucidate in detail why BAG3 appears to have a preference for
aB-crystallin R120G.
BAG family proteins have a conserved Hsc70-interacting
domain at their C-termini and regulate protein-folding activities
[13,31]. On the other hand, the N-terminal sequences of BAG
family proteins are different and have distinct functions [16,32,33].
BAG1 possesses a Ubl domain (Ubiquitin-like domain) that binds
Figure 4. BAG3 attenuates the toxicity of mutant aB-crystallin.
BAG3 inhibits apoptosis caused by aB-crystallin mutant in C2C12 cells. aB-
crystallin wild type or R120G was expressed with or without Flag-
tagged BAG3 in C2C12 myoblast cells, and cells were cultured with
differentiation media to induce myotube differentiation. After fixing
cells, aB-crystallin and cell nuclei were stained with anti-aB-crystallin
antibody and Dapi solution, respectively. Cells with nuclear fragmen-
tation typical of apoptosis were counted and statistically analyzed.
doi:10.1371/journal.pone.0016828.g004
for 15 minutes at 4uC. The supernatant was transferred to a new tube to represent the soluble fraction. The samples were subjected to an
immunoblotting assay to detect aB-crystallin (first panel), Flag-tagged BAG3 (second panel), actin (third panel), and GFP (last panel). (E) BAG3 clears
aggregation of mutant aB-crystallin independent with Hsc70. HEK293 cells were transfected with indicated plasmids, and cultured for two days. Panel
#1 (upper three panel): wild type aB-crystallin+pcDNA3 empty vector (mock). Panel #2–7 represents transfectants of aB-crystallin R120G mutant
with plasmid indicated at the left of each three panels. After fixation, aB-crystallin (aBCry) and Flag-tagged proteins were stained with anti-aB-
crystallin antibody (red in color images) and Flag-antibody (green in color images), respectively. Merged images are also shown (Merge). The number
of cells containing aB-crystallin R120G aggregation were counted and statistically analyzed. The percentage of cells displaying aB-crystallin
aggregation is shown in the right panel. (F) Expression of Hsc70 and BAG3 proteins in HEK293 cells used above. HEK293 cells were transfected with
plasmids for aB-crystallin with or without Flag-BAG3 or Flag-Hsc70. Two days later, cells were lysed for western blotting. The expression levels of
Hsc70 and BAG3 proteins in HEK293 cells were verified using anti-Hsc70 antibody (Hsc70), anti-BAG3 antibody (BAG3), and anti-Flag antibody (Flag).
Actin was used as a loading control (actin). Hsc70 antibody detected endogenous Hsc70 as shown at the left three lanes in the second panel and
overexpressed Flag tagged Hsc70 with endogenous protein at the right three lanes. Flag antibody detected BAG3FL (2 and 5 lane), BAG3nC (3 and 6
lane) and Hsc70 (4, 5 and 6 lane).
doi:10.1371/journal.pone.0016828.g003
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to the 26S proteasome, suggesting a function for this protein in
protein folding and degradation. Involvement of BAG1 in
neurodegenerative disease has been documented for Alzheimer’s
and Huntington’s disease as well as Amyotrophic lateral sclerosis
[34,35,36]. In this report, we found that BAG3 directly binds to
and enhances the solubility of mutant aB-crystallin R120G and
inhibits its aggregation. Finally, the toxicity caused by aB-crystallin
was attenuated by overexpression of BAG3. BAG3 is the first co-
chaperone molecule that bridges two major molecular chaperones,
Hsc70/Hsp70, and small heat shock proteins (at least HspB6, B8
and aB-crystallin). We anticipate that investigation of BAG3 and
the two major chaperone interactions (small heat shock proteins
and Hsp70/Hsc70) will reveal potential therapeutic approaches
for myofibrillar myopathy and other aggregation/degenerative
diseases.
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